Danazol linked to ovarian cancer.
Weideman
Mary
M
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D003613:Danazol / Q000009:adverse effects* / Q000627:therapeutic use; D004715:Endometriosis / Q000188:drug therapy / Q000378:metabolism; D004965:Estrogen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000139:chemically induced*
D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D016729:Leuprolide; D003613:Danazol